The Centers for Medicare & Medicaid Services today issued a final rule that increases overall Medicare payments to end-stage renal disease facilities by 0.2% in calendar year 2016. Hospital-based facilities will see a 0.2% increase. The Protecting Access to Medicare Act of 2014 required a reduced ESRD bundled market-basket update for CY 2016 of 0.15%, resulting in a 2016 ESRD prospective payment system base rate of $230.39 after productivity and wage index budget-neutrality adjustments. CMS also finalized one new measure for the ESRD Quality Incentive Program for payment year 2019. Specifically, CMS replaced four dialysis adequacy measures with a single clinical measure. The agency did not finalize proposed quality reporting measures for ultrafiltration rate and flu vaccination. The changes are effective Jan. 1, 2016.